Program Operations Manual System (POMS)
TN 35 (08-20)
DI 23022.685 Carcinoma of Unknown Primary Site
COMPASSIONATE ALLOWANCES INFORMATION
|
CARCINOMA OF UNKNOWN PRIMARY SITE
|
ALTERNATE NAMES
|
Cancer of Unknown Primary Origin; CUP; Origin of Unknown Primary Site; Occult Primary
Malignancy; Occult Primary Cancer; Malignant Neoplasms of Unknown site; Malignant
Neoplasms of Unknown Origin
|
DESCRIPTION
|
Carcinoma of Unknown Primary Site (CUP) is a condition where cancer cells are found in the body, but the place where the cells
first started growing (the origin or primary site) cannot be determined. The clinical
presentation of cancer of unknown primary origin is extremely variable, and depends
on the extent and type of organ involvement.
Most people with CUP present with multiple areas of involvement in multiple visceral
sites (organs in the cavities of the body), the most common sites of involvement being
lung, bone, lymph nodes, and liver. Individuals with CUP are presumed to all have
stage IV disease at the time of initial presentation.
|
DIAGNOSTIC TESTING, PHYSICAL FINDINGS, AND
ICD-9-CM/ICD-10-CM
CODING
|
Diagnostic testing: Diagnostic testing for CUP includes biopsy, imaging studies, and laboratory analysis.
Physical findings: Individuals with CUP may have:
-
•
Long-lasting pain in a specific area of the body;
-
-
-
•
A cough or hoarseness that doesn’t go away;
-
•
Thickening or lump in any part of the body;
-
•
Changes in bowel or bladder habits;
-
•
Unusual bleeding or discharge; and
-
•
Recurring fever or night sweats.
ICD-9:
199.1
ICD-10: C80.1
|
PROGRESSION
|
The incidence of CUP increases with age, with the median age on presentation for both
men and women ranging from 59-66 years. The overall prognosis of patients with cancer
of unknown primary origin with multiple organ involvement and poor response to treatment
is grave.
|
TREATMENT
|
The treatment for CUP is dependent on organ involvement.
|
SUGGESTED PROGRAMMATIC ASSESSMENT*
|
Suggested MER for Evaluation:
-
•
Clinical history and examination that describes the diagnostic features of the impairment;
-
-
•
Pathology/biopsy report of the cancer; and
-
•
Treatment records including surgical procedures, and up-to-date progress notes.
|
Suggested Listings for Evaluation:
|
DETERMINATION
|
LISTING
|
REMARKS
|
Meets
|
13.27
|
CUP meets the criteria in listing 13.27 upon confirmed diagnosis, regardless of effectiveness
of treatment, except squamous cell carcinoma of unknown primary site confined to the
neck nodes, which we evaluate under listing 13.02.
|
Equals
|
|
|
* Adjudicators may, at their discretion, use the Medical Evidence of Record or the
listings suggested to evaluate the claim. However, the decision to allow or deny the
claim rests with the adjudicator.
|